Spectrum of Ocular Manifestations in CLN2-Associated Batten (Jansky-Bielschowsky) Disease Correlate with Advancing Age and Deteriorating Neurological Function

Спектр глазных проявлений болезни Баттена, ассоциированной с CLN2 (болезни Янского—Бильшовского), коррелирует с увеличением возраста и ухудшением неврологической функции
Ronald G. Crystal, Michael G. Kaplitt, Stephen M. Kaminsky, Szilárd Kiss, Anton Orlin, Kaleb H. Yohay, Barry E. Kosofsky, Donald J. D’Amico, Neil R. Hackett, Mark M. Souweidane, Matthew T. Witmer, Dolan Sondhi, Matthew M. Wessel, Jason G. Mezey
2013-08-28

CLN2-associated Batten diseaseLINCL Ophthalmic Scalelate infantile neuronal ceroid lipofuscinosisophthalmic manifestationsoptical coherence tomography
BACKGROUND: Late infantile neuronal ceroid lipofuscinosis (LINCL), one form of Batten's disease is a progressive neurodegenerative disorder resulting from a CLN2 gene mutation. The spectrum of ophthalmic manifestations of LINCL and the relationship with neurological function has not been previously described. METHODS: Patients underwent ophthalmic evaluations, including anterior segment and dilated exams, optical coherence tomography, fluorescein and indocyanine green angiography. Patients were also assessed with the LINCL Neurological Severity Scale. Ophthalmic findings were categorized into one of five severity scores, and the association of the extent of ocular disease with neurological function was assessed. RESULTS: Fifty eyes of 25 patients were included. The mean age at the time of exam was 4.9 years (range 2.5 to 8.1). The mean ophthalmic severity score was 2.6 (range 1 to 5). The mean neurological severity score was 6.1 (range 2 to 11). Significantly more severe ophthalmic manifestations were observed among older patients (p<0.005) and patients with more severe neurological findings (p<0.03). A direct correlation was found between the Ophthalmic Severity Scale and the Weill Cornell Neurological Scale (p<0.002). A direct association was also found between age and the ophthalmic manifestations (p<0.0002), with older children having more severe ophthalmic manifestations. CONCLUSIONS: Ophthalmic manifestations of LINCL correlate closely with the degree of neurological function and the age of the patient. The newly established LINCL Ophthalmic Scale may serve as an objective marker of LINCL severity and disease progression, and may be valuable in the evaluation of novel therapeutic strategies for LINCL, including gene therapy.
1
A cohort of 25 patients with CLN2-associated late-infantile neuronal ceroid lipofuscinosis underwent comprehensive ophthalmic and neurological assessment.
2
More severe ocular findings were significantly associated with worse neurological function (p<0.03), with a direct correlation between ophthalmic and Weill Cornell neurological severity scales (p<0.002).
3
Ophthalmic severity increased significantly with patient age, with older children showing more advanced ocular manifestations (p<0.0002).
4
The newly established LINCL Ophthalmic Scale may provide an objective marker of disease severity and progression for evaluating potential therapies, including gene therapy.

Patients with CLN2-associated late-infantile neuronal ceroid lipofuscinosis (LINCL; Batten disease) and its ophthalmic manifestations

The spectrum and severity of ophthalmic manifestations and their correlations with patient age and neurological function

Publication Details
Publication Date
2013-08-28
Journal
Publisher
ISSN
Cited by
54
Access Type
Author Information
Authors
Ronald G. Crystal
Michael G. Kaplitt
Stephen M. Kaminsky
Szilárd Kiss
Anton Orlin
Kaleb H. Yohay
Barry E. Kosofsky
Donald J. D’Amico
Neil R. Hackett
Mark M. Souweidane
Matthew T. Witmer
Dolan Sondhi
Matthew M. Wessel
Jason G. Mezey
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%